United states

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years – CNBC

4 days ago
0 Views
1 Min Read
  1. Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years  CNBC
  2. Semaglutide, or Ozempic, reduces symptoms of feared diabetes’ complication, study finds  The Globe and Mail
  3. Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025  Yahoo Finance
  4. STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients  TCTMD
  5. SOUL: Oral Semaglutide Cuts MACE by 14% in People with Type 2 Diabetes  MD Magazine

Add Comment

Click here to post a comment